Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
PharmAbcine Announces Poster Presentations on Its anti-VISTA Antibody Candidate at SITC 2022
2022-10-17 20:00
Tianfu International Biocity: Build Global Bioindustry-city
2022-10-14 20:48
WuXi Biologics Receives "Best CDMO Award of the Year"
2022-10-14 09:00
Alterity Therapeutics Launches ATH434 Phase 2 Clinical Trial in Australia for the Treatment of Individuals with Multiple System Atrophy
2022-10-13 22:25
Neurophth Therapeutics Conducts Special Interview with Dr. Satoshi Kashii on World Sight Day
2022-10-13 20:30
Harbour BioMed Announces Upcoming Poster Presentations at the 37th Society for Immunotherapy of Cancer Annual Meeting
2022-10-13 19:05
Samsung Biologics obtains three global ISO certifications
2022-10-13 19:00
Great Bay Bio Announces Official Launch of Site-Specific Integration Platform for Cell Line Development, AlfaCell®
2022-10-11 20:40
HanAll's Licensed Partner in China Enters Sublicense Agreement with CSPC to Further Accelerate Development of Batoclimab
2022-10-11 19:00
Samsung Biologics unlocks additional capacity for production at its newest Plant 4
2022-10-11 19:00
Antengene Announces Upcoming Presentations at the 2022 Society for Immunotherapy of Cancer Annual Meeting
2022-10-08 10:43
First patient treated in Clarity's therapeutic prostate cancer trial
2022-10-07 21:06
HanAll's Second FcRn Inhibitor HL161ANS to be Added to the Development Program of its Licensed Partner
2022-10-04 19:00
Hayashibara Brings Back "Trehalose Symposium" to Reveal Its Game-changing Versatilities in Human Biochemistry
2022-10-04 14:00
Samsung Biologics introduces new development platforms S-DUAL™ and DEVELOPICK™ at BPI Boston 2022
2022-09-29 19:00
NeuShen Therapeutics Closes Pre-A Financing with ~$20M
2022-09-29 17:50
Kintor Pharma Announces Publication of Phase Ib Data from Pruxelutamide for AR+ mBC in EJC
2022-09-29 14:22
GC Labs becomes the first Korean laboratory to obtain certification of CDC standardization programs (VDSCP & HoSt)
2022-09-29 08:17
First-Ever Spinal Surgical Hand-held Robot by Point Robotics MedTech to Make Its Worldwide Debut in the United States
2022-09-28 21:01
Samsung Biologics Earns Gold Rating from EcoVadis for Its Sustainability Efforts
2022-09-28 19:00
1
70
71
72
73
74
222